Clinical use of photodynamic therapy in ocular tumors.

Eren Cerman, Osman Çekiç

Journal: Survey of ophthalmology 2016;60(6):557-74

PMID: 26079736

Full Text on Elsevier Science View on PubMed

Abstract

Although the introduction of intravitreal anti-vascular endothelial growth factor drugs reduced the indications for photodynamic therapy in ophthalmology, it may still be used in various ocular tumors. Although many studies have shown that photodynamic therapy is effective in ocular tumors, the literature consists of case reports and series. In this review, we systematically performed a meta-analysis for the use of photodynamic therapy in circumscribed choroidal hemangioma, diffuse choroidal hemangioma, retinal capillary hemangioma, von Hippel-Lindau angiomatosis, choroidal melanoma, retinal astrocytoma, retinoblastoma, eyelid tumors, conjunctival tumors, and choroidal metastasis.

Address: Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey.; Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey. Electronic address: [email protected].

DOI: 10.1016/j.survophthal.2015.05.004

Link outs

Free resources

Medical:

https://medlineplus.gov/eyecancer.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Astrocytoma, Choroid Neoplasms, Conjunctival Neoplasms, Eye Neoplasms, Eyelid Neoplasms, Hemangioma, Hemangioma, Capillary, Humans, Melanoma, Photochemotherapy, Photosensitizing Agents, Retinal Neoplasms, Retinoblastoma